UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031443
Receipt number R000035901
Scientific Title A clinical study to evaluate the effects of dextrin on maintaining hydration status
Date of disclosure of the study information 2018/02/23
Last modified on 2023/08/29 11:37:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A clinical study to evaluate the effects of dextrin on maintaining hydration status

Acronym

A clinical study to evaluate the effects of dextrin on maintaining hydration status

Scientific Title

A clinical study to evaluate the effects of dextrin on maintaining hydration status

Scientific Title:Acronym

A clinical study to evaluate the effects of dextrin on maintaining hydration status

Region

Japan


Condition

Condition

None

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effects of the intake of beverage containing dextrin on maintaining hydration status in a randomized, double-blind, placebo-controlled, crossover study

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Rate of water absorption

Key secondary outcomes

Water retention, Changes of blood glucose


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Intake of test food -> Washout for 1 week -> Intake of Placebo

Interventions/Control_2

Intake of Placebo -> Washout for 1 week -> Intake of test food

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

55 years-old >

Gender

Male

Key inclusion criteria

1) Subjects whose age of 20 years or more and less than 55 years
2) Subjects receiving a sufficient briefing of the objective and content of the present study, fully understanding and agreeing to voluntary participate in the study and being able to personally sign a written informed consent

Key exclusion criteria

1) Subjects having serious hepatic, cardio-vascular, respiratory, endocrine or metabolic disorders
2) Subjects who have a seasonal allergic rhinitis (cedar or Japanese cypress pollen) with moderate or severe symptoms
3) Subjects having blood sample of 200 ml or more taken within 1 month, or 400 ml or more within 3 months prior to the start of the present study (e.g. donated blood)
4) Subjects who took part in another clinical study within 3 months prior to the start of the present study or who is currently taking part in another clinical study
5) Subjects deemed unsuitable by the investigator

Target sample size

12


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshinobu Terada

Organization

EZAKI GLICO CO., LTD.

Division name

Institute of Health Sciences

Zip code


Address

4-6-5, Utajima, Nishiyodogawa-ku, Osaka

TEL

06-6477-8425

Email

terada-yoshinobu@glico.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tomohiro Sugino

Organization

Soiken Inc.

Division name

Representative Director

Zip code


Address

Senri Life Science Center 13F, 1-4-2, Shinsenri-higashimachi, Toyonaka, Osaka

TEL

06-6871-8888

Homepage URL


Email

sugino@soiken.com


Sponsor or person

Institute

Soiken Inc.

Institute

Department

Personal name



Funding Source

Organization

EZAKI GLICO CO., LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 02 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 01 Month 20 Day

Date of IRB

2018 Year 01 Month 20 Day

Anticipated trial start date

2018 Year 02 Month 24 Day

Last follow-up date

2018 Year 03 Month 11 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 02 Month 23 Day

Last modified on

2023 Year 08 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035901


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name